Molnlycke completes investment programme at Oldham facility

Medical Company Restructures

Molnlycke has announced the completion of a 2.2 million pound investment programme at its UK factory in Oldham that will expand the capabilities of the site.

Designed to increase the competitiveness and diversify the production line of the facility, the project has taken just over a year to complete and results in the creation of 25 new jobs, equivalent to a ten percent headcount increase.

“Molnlycke has spent 2.2 million pounds to expand the capabilities of its UK production site in Oldham, resulting in the creation of 25 new jobs.“

The site currently produces tubular bandages such as Tubifast and Tubigrip and skin care products including the Epaderm cream and ointment, but the new investment means it will now also be able to manufacture wound irrigation sachets like Unisept and Tisept.

Molnlycke has been operating the factory since 2005, when it completed the acquisition of Medlock Medical.

Nick Douglas, Molnlycke Health Care's factory manager in Oldham, said: "An investment of this magnitude is a significant commitment and shows that Oldham will play an important role in Molnlycke Health Care's future production portfolio."

This comes after the firm opened a new US manufacturing and converting facility in Brunswick, Maine last month.

See all the latest jobs in Medical Devices
Return to news

Tags